TY  - GEN
AU  - Slamon,D
AU  - Pegram,M
TI  - Rationale for trastuzumab (Herceptin) in adjuvant breast cancer trials
SN  - 0093-7754
PY  - 2001///0426
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Humanized
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Cisplatin
KW  - Clinical Trials as Topic
KW  - Docetaxel
KW  - Drug Synergism
KW  - Genes, erbB-2
KW  - Heart Failure
KW  - chemically induced
KW  - Humans
KW  - Paclitaxel
KW  - Prognosis
KW  - Proto-Oncogene Mas
KW  - Taxoids
KW  - Trastuzumab
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1016/s0093-7754(01)90188-5
ER  -